XPOVIO® is the first XPO1 inhibitor approved in Taiwan for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM).
BANGKOK,Feb. 13,2025-- During a meeting with Thailand\'s Prime Minister,Ms.Paetongtarn Shinawatra,in Bangkok today,Mr. Masahiro Moro,President and CEO of Mazda Motor Corporation announced that the com
JAKARTA,Indonesia,Feb. 13,2025-- Gupshup,the world\'s leading Conversational AI platform today announced the launch of its AI Agent Library,a groundbreaking suite of 15 pre-built and customizable AI
TOKYO,Feb. 13,2025-- The global energy sector is gearing up for one of the most anticipated events of the year. From February 19 to 21,2025,Ampace and TDK will jointly exhibit at Tokyo Big Sight (Boot
CANGZHOU,China,Feb. 13,2025-- A news report from xinhuanet: The Year of the Snake ushers in an energetic Spring Festival in Cangzhou,Hebei Province. Locals and tourists alike are reveling in the festi
BEIJING,Feb. 13,2025-- A report from People\'s Daily: The ongoing 9th Asian Winter Games held in Harbin,northeast China\'s Heilongjiang province,themed "Dream of Winter,Love Among Asia," emb